Literature DB >> 22286771

Fluorodeoxyglucose PET/CT in subcutaneous sarcoidosis mimicking cutaneous lymphoma.

Marcel P M Stokkel1, Bernies van der Hiel, Renato Valdés Olmos, Kees Hoefnagel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22286771     DOI： 10.1007/s00259-012-2068-1

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  5 in total

1.  Cutaneous sarcoidosis evaluated by FDG PET.

Authors:  Yuxin Li; Gholam R Berenji
Journal:  Clin Nucl Med       Date:  2011-07       Impact factor: 7.794

2.  Characterization of T-cell lymphomas by FDG PET/CT.

Authors:  John Feeney; Steven Horwitz; Mithat Gönen; Heiko Schöder
Journal:  AJR Am J Roentgenol       Date:  2010-08       Impact factor: 3.959

3.  Specific cutaneous lesions in patients with systemic sarcoidosis: relationship to severity and chronicity of disease.

Authors:  J Marcoval; J Mañá; M Rubio
Journal:  Clin Exp Dermatol       Date:  2011-07-25       Impact factor: 3.470

Review 4.  Subcutaneous sarcoidosis: report of two cases and review of the literature.

Authors:  Camilla Dalle Vedove; Chiara Colato; Giampiero Girolomoni
Journal:  Clin Rheumatol       Date:  2011-04-02       Impact factor: 2.980

5.  Interpretation, accuracy and management implications of FDG PET/CT in cutaneous malignant melanoma.

Authors:  Matthew S Falk; Anne K Truitt; Fergus V Coakley; Mohammed Kashani-Sabet; Randall A Hawkins; Benjamin Franc
Journal:  Nucl Med Commun       Date:  2007-04       Impact factor: 1.690
  5 in total
  1 in total

1.  Asymptomatic tiny subcutaneous eruptions in a patient with sarcoid neuropathy: the effectiveness of fluorine-18 fluorodeoxyglucose positron emission tomography for targeting safe biopsy sites.

Authors:  Makoto Kobayashi
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2019-05-01       Impact factor: 0.670
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.